Earkart Limited Incorporates US Subsidiary Earkart Inc. for American Market Expansion
Earkart Limited has incorporated wholly owned subsidiary Earkart Inc. in Delaware, United States, on 20th January 2026 to expand its hearing-care business in the American market. The subsidiary is authorized to issue 1,000 shares of common stock at $0.1 par value, all fully subscribed by the parent company for 100% ownership. Earkart Inc. will focus on developing remote audiology platforms, hearing tests, hearing aid distribution, and digital health solutions while partnering with healthcare providers and retailers across the United States.

*this image is generated using AI for illustrative purposes only.
Earkart Limited has successfully incorporated a wholly owned subsidiary in the United States as part of its strategic expansion into the American hearing-care market. The company informed BSE Limited about this development through a regulatory filing under Regulation 30 of the SEBI Listing Regulations on 26th February 2026.
Subsidiary Incorporation Details
The new subsidiary, Earkart Inc., was incorporated in Delaware on 20th January 2026 through Corporate Bylaws. The company subsequently received its Employer Identification Number (EIN) on 20th February 2026, completing the formal incorporation process.
| Parameter: | Details |
|---|---|
| Subsidiary Name: | Earkart Inc. |
| Incorporation Date: | 20th January 2026 |
| EIN Received: | 20th February 2026 |
| Employer Identification Number: | 30-1479110 |
| Registered Office: | 16192 Coastal Highway, Lewes, Delaware 19958 |
| Registered Agent: | Harvard Business Services, Inc. |
Share Structure and Ownership
Earkart Inc. has been authorized to issue 1,000 shares of common stock with a par value of $0.1 per share. Earkart Limited has fully subscribed to all 1,000 shares, maintaining 100% ownership of the subsidiary. The parent company will pay the subscription amount in cash for the shares.
| Share Details: | Specifications |
|---|---|
| Authorized Shares: | 1,000 shares |
| Par Value: | $0.1 per share |
| Share Class: | Common stock |
| Ownership: | 100% by Earkart Limited |
| Consideration: | Cash payment |
Business Objectives and Operations
The subsidiary will operate in the hearing-care and audiology sector, focusing on the development and scaling of compliant remote audiology services in the United States. Earkart Inc.'s business scope encompasses multiple aspects of hearing healthcare delivery and product distribution.
Key Business Activities:
- Developing and operating compliant remote audiology platforms
- Providing accurate hearing tests and professional audiology services
- Hearing aid fitting, distribution, and sales of affordable hearing aids
- Offering related digital health solutions
- Partnering with ENT and audiology clinics, insurers, pharmacies, and large retailers
- Trading, manufacturing, marketing, and distribution of ear-health and hearing-protection products
Strategic Significance
The incorporation of Earkart Inc. represents a significant step in Earkart Limited's international expansion strategy. According to the company's filing, the wholly owned subsidiary will play a crucial role in advancing the holding company's business expansion in the United States hearing-care market.
The subsidiary's registered office is located at 16192 Coastal Highway, Lewes, Delaware, with Harvard Business Services, Inc. serving as the registered agent. The Certificate of Incorporation was signed by Michael J. Bell, President of Harvard Business Services, Inc., acting as the incorporator.
This development positions Earkart Limited to tap into the American hearing-care market through its dedicated US entity, potentially enabling better market penetration and compliance with local regulations in the healthcare sector.































